Semak Pharma to double investments in 2027, expand Fayoum production
Source ↗
👁 0
💬 0
Semak Pharmaceutical Group plans to double its current investment volume in 2027, with an expansion strategy focused on increasing production capacity, broadening its personal care portfolio and expanding distribution across Egyptian pharmacies.
The company’s expansion plans centre on its manufacturing facility, Brand FSC (Brand Pharma), in Fayoum, which spans approximately 15,600 sqm. The facility is expected to support higher production volumes and the development of personal and skincare prod
The company’s expansion plans centre on its manufacturing facility, Brand FSC (Brand Pharma), in Fayoum, which spans approximately 15,600 sqm. The facility is expected to support higher production volumes and the development of personal and skincare prod
Comments (0)